Cargando…

Assessment of the Effect of Infliximab on Immunomodulation Properties of Mesenchymal Stem Cells In Vitro

Purpose: Mesenchymal stem cells (MSCs) have immunomodulatory traits making them a promising choice in the treatment of inflammatory diseases such as graft-versus-host disease (GVHD). Tumor necrosis factor-alpha (TNFα) is a major player of inflammatory disease which is blocked by infliximab to reduce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakha, Yasaman Aliasghari, Ehsani, Ehsan, Roshandel, Elham, Jalili, Arsalan, Vahdani, Negar, Hajifathali, Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642797/ https://www.ncbi.nlm.nih.gov/pubmed/34888221 http://dx.doi.org/10.34172/apb.2021.083

Ejemplares similares

Signaling pathways involved in chronic myeloid leukemia pathogenesis: The importance of targeting Musashi2-Numb signaling to eradicate leukemia stem cells
por: Moradi, Foruzan, et al.
Publicado: (2019)

The Impact of Different Cell Culture Mediums on CD8+T Cells Expansion: A Bioinformatics Study
por: Jalili, Arsalan, et al.
Publicado: (2022)

Virus-Specific T Cells: Promising Adoptive T Cell Therapy Against Infectious Diseases Following Hematopoietic Stem Cell Transplantation
por: Jalili, Arsalan, et al.
Publicado: (2023)

Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients
por: Roshandel, Elham, et al.
Publicado: (2021)

Association of Interleukin 10 (IL-10) Gene Polymorphism (819T > C) with Susceptibility to Acute Myeloid Leukemia: A Meta-Analysis
por: Ahadi, Hamid Reza, et al.
Publicado: (2022)

The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation
por: Tabasi, Shabnam, et al.
Publicado: (2021)

Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application
por: Wang, Mengyuan, et al.
Publicado: (2018)

HOTAIR Long Noncoding RNA is not a Biomarker for Acute Myeloid Leukemia (AML) in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2017)

Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience
por: Mehdizadeh, Mahshid, et al.
Publicado: (2021)

The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2014)

An Intelligent Clinical Decision Support System for Predicting Acute Graft-versus-host Disease (aGvHD) following Allogeneic Hematopoietic Stem Cell Transplantation
por: Salehnasab, Cirruse, et al.
Publicado: (2021)

Decidual stromal cell therapy for generalized lymphadenopathy as a special clinical manifestation of COVID‐19 infection: A case report
por: Pirsalehi, Ali, et al.
Publicado: (2022)

Cell-Based Therapy Approaches in Treatment of Non-obstructive Azoospermia
por: Roshandel, Elham, et al.
Publicado: (2022)

Roles of Mesenchymal Stem Cells in Tissue Regeneration and Immunomodulation
por: Ayala-Cuellar, Ana Patricia, et al.
Publicado: (2019)

Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
por: Berkowitz, Joshua C, et al.
Publicado: (2018)

Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes
por: Ma, Oscar Ka-Fai, et al.
Publicado: (2016)

Association of HScore Parameters with Severe COVID-19: A Systematic Review and Meta-Analysis
por: Hossein Kazemi, Mohammad, et al.
Publicado: (2021)

The effect of granulocyte colony‐stimulating factor dose and administration interval after allogeneic hematopoietic cell transplantation on early engraftment of neutrophil and platelet
por: Noorazar, Leila, et al.
Publicado: (2021)

Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation
por: Kuo, Yur-Ren, et al.
Publicado: (2012)

Mesenchymal stem cells and immunomodulation: current status and future prospects
por: Gao, F, et al.
Publicado: (2016)

Differences of Clonogenic Mesenchymal Stem Cells on Immunomodulation of Lymphocyte Subsets
por: Martínez-Peinado, Pascual, et al.
Publicado: (2018)

Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease
por: Momeni-Varposhti, Zahra, et al.
Publicado: (2020)

On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation
por: Engela, Anja U., et al.
Publicado: (2012)

Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis
por: Lin, Tzuhua, et al.
Publicado: (2017)

Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application
por: Lee, Byung-Chul, et al.
Publicado: (2020)

Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation
por: Gomzikova, Marina O., et al.
Publicado: (2019)

DNA methyltransferase inhibition accelerates the immunomodulation and migration of human mesenchymal stem cells
por: Lee, Seunghee, et al.
Publicado: (2015)

Impact of bone marrow mesenchymal stem cell immunomodulation on the osteogenic effects of laponite
por: Li, Tao, et al.
Publicado: (2018)

Mesenchymal Stem Cells Secretory Responses: Senescence Messaging Secretome and Immunomodulation Perspective
por: Lunyak, Victoria V., et al.
Publicado: (2017)

Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation
por: Xiao, E, et al.
Publicado: (2017)

Cytokines Differently Define the Immunomodulation of Mesenchymal Stem Cells from the Periodontal Ligament
por: Behm, Christian, et al.
Publicado: (2020)

Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease
por: Wang, Yueyao, et al.
Publicado: (2022)

ERK1-mediated immunomodulation of mesenchymal stem cells ameliorates inflammatory disorders
por: Zhang, Qing, et al.
Publicado: (2023)

Immunomodulation of Pluripotent Stem Cell-Derived Mesenchymal Stem Cells in Rotator Cuff Tears Model
por: Baek, Jieun, et al.
Publicado: (2022)

A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
por: Lichtenstein, Gary R, et al.
Publicado: (2012)

N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin via immunomodulation responses
por: Maghsadi, Zahra, et al.
Publicado: (2023)

Immunomodulation by Mesenchymal Stem Cells : A Potential Therapeutic Strategy for Type 1 Diabetes
por: Abdi, Reza, et al.
Publicado: (2008)

Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis
por: Liu, Ming, et al.
Publicado: (2016)

Neuroprotection and immunomodulation following intraspinal axotomy of motoneurons by treatment with adult mesenchymal stem cells
por: Spejo, A. B., et al.
Publicado: (2018)

Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion
por: Kadle, Rohini L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m80358a9f8afpavn5lv57lnrh5